Stay updated on Pembrolizumab in Untreated B-Cell NHL Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Untreated B-Cell NHL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Untreated B-Cell NHL Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T14:07:32.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The study page for NCT03498612 now renders a 403 Forbidden page, replacing the usual study details. Users attempting to view the record will see the 403 page instead of trial content.
    Difference
    19%
    Check dated 2026-09-19T18:09:30.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The revision indicator on the page was updated from v3.6.5 to v3.6.6, reflecting a newer site version.
    Difference
    0.1%
    Check dated 2026-08-29T20:32:29.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The page changed from an error page to a full study record for NCT03498612, adding the study overview, design details, eligibility criteria, locations, outcomes, and links to related documents such as the Study Protocol and Statistical Analysis Plan.
    Difference
    52%
    Check dated 2026-08-15T18:48:55.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Revision: v3.6.5 replaces v3.6.4 on the page. This appears to be a small site maintenance update rather than a change to the study information.
    Difference
    0.1%
    Check dated 2026-08-08T15:37:37.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    The page now shows a revised tag, updating from v3.6.3 to v3.6.4, indicating a minor site update. This does not alter study details or how the page operates.
    Difference
    0.1%
    Check dated 2026-07-25T07:38:53.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Untreated B-Cell NHL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Untreated B-Cell NHL Clinical Trial page.